Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad

The USFDA conducted a Pre-Approval Inspection at SEZ Oncology Injectable manufacturing site in SEZ1, Ahmedabad, in relation to the new isolator injectable line. The inspection was conducted from 4th to 13th November, 2025 and concluded with two observations. There were no data integrity related observations. The Company will closely work with the USFDA to address the observations expeditiously.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 944.20 as compared to the previous close of Rs. 951.20. The total number of shares traded during the day was 8582 in over 740 trades.

The stock hit an intraday high of Rs. 959.45 and intraday low of 940.20. The net turnover during the day was Rs. 8120121.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals USFDA PreApprovalInspection SEZ OncologyInjectableFacility Ahmedabad